In addition, the absence of resistance of peptides to breakdown by gastrointestinal proteolytic enzymes (e.g., carboxypeptidases or aminopeptidases) should be mentioned [8], which in practice precludes administrating such a drug to the patient orally and calls for intravenous administration
Any temperature excursion above 8C accelerates peptide aggregation
Mar 6 2020;9(3)doi:10.3390/antiox9030219
Patents for IN delivery of new formulations to the CNS, patents for IN delivery of peptides/proteins to the CNS, patents explaining delivery devices for IN delivery to the CNS, and patents for IN delivery of synthetic drugs to the CNS are some of the types of patents filed on IN delivery to the brain
tDCS is primarily conducted in the brain via a constant current through scalp electrodes
Some people research BPC-157 for tendon, ligament, joint, and muscle recovery